Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-25-001493

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 15, 2025 9.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.53M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 2.99M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.68M sh
Capex Q2 2025 · Jun 30, 2025 $18K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$208.89K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$92.64K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$1.14M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$1.57M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$1.46M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$1.92M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$1.8M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$1.65M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.41M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.41M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.73M
Current Assets Q2 2025 · Jun 30, 2025 $255.52K
Current Assets Q2 2025 · Dec 31, 2024 $261.89K
Total Assets Q2 2025 · Jun 30, 2025 $272.52K
Total Assets Q2 2025 · Dec 31, 2024 $261.89K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2025 $0.04
Eps Diluted Q2 2025 · Jun 30, 2024 $0.06
Eps Diluted Q2 2025 · Jun 30, 2024 $0.13
Sga Expense Q2 2025 · Jun 30, 2025 $197.89K
Sga Expense Q2 2025 · Jun 30, 2025 $341.28K
Sga Expense Q2 2025 · Jun 30, 2024 $4.62K
Sga Expense Q2 2025 · Jun 30, 2024 $36.29K
Net Income Q2 2025 · Jun 30, 2025 −$157.91K
Net Income Q2 2025 · Jun 30, 2025 −$355.05K
Net Income Q2 2025 · Mar 31, 2025 −$197.14K
Net Income Q2 2025 · Jun 30, 2024 −$183.02K
Net Income Q2 2025 · Jun 30, 2024 −$489.72K
Net Income Q2 2025 · Mar 31, 2024 −$306.71K
Operating Income Q2 2025 · Jun 30, 2025 −$279.22K
Operating Income Q2 2025 · Jun 30, 2025 −$528.37K
Operating Income Q2 2025 · Jun 30, 2024 −$92.98K
Operating Income Q2 2025 · Jun 30, 2024 −$142.81K
Gross Profit Q2 2025 · Jun 30, 2025 $1.06K
Gross Profit Q2 2025 · Jun 30, 2025 $1.06K
Gross Profit restated Q2 2025 · Jun 30, 2024 $429
Gross Profit restated Q2 2025 · Jun 30, 2024 $4.03K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.16K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.16K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $246
Cost Of Revenue Q2 2025 · Jun 30, 2024 $8.64K
Revenue Q2 2025 · Jun 30, 2025 $3.22K
Revenue Q2 2025 · Jun 30, 2025 $3.22K
Revenue Q2 2025 · Jun 30, 2024 $675
Revenue Q2 2025 · Jun 30, 2024 $12.67K